|
YY2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.589400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.845400E-01 |
| Normal-vs-Stage2 |
6.935800E-01 |
| Normal-vs-Stage3 |
6.185400E-01 |
| Normal-vs-Stage4 |
3.436600E-01 |
| Stage1-vs-Stage2 |
9.384800E-01 |
| Stage1-vs-Stage3 |
8.214600E-01 |
| Stage1-vs-Stage4 |
7.210800E-01 |
| Stage2-vs-Stage3 |
9.509400E-01 |
| Stage2-vs-Stage4 |
7.550400E-01 |
| Stage3-vs-Stage4 |
6.369000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.332000E-01 |
| Normal-vs-AfricanAmerican |
1.698240E-01 |
| Normal-vs-Asian |
1.010980E-01 |
| Caucasian-vs-AfricanAmerican |
1.805580E-01 |
| Caucasian-vs-Asian |
1.279830E-01 |
| AfricanAmerican-vs-Asian |
8.862800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.546800E-01 |
| Normal-vs-Female |
1.134750E-01 |
| Male-vs-Female |
9.296700E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.322600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.497600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.345800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.209900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.571400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.091200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.918020E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.421600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.655700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.992400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.104800E-01 |
| Classical-VS-Follicular |
4.73310000004279E-06 |
| Classical-VS-Other |
2.388000E-02 |
| Classical-VS-Normal |
2.855700E-02 |
| Tall-VS-Follicular |
4.897300E-03 |
| Tall-VS-Other |
4.410200E-02 |
| Tall-VS-Normal |
1.957610E-01 |
| Follicular-VS-Other |
3.966000E-01 |
| Follicular-VS-Normal |
3.050200E-02 |
| Other-VS-Normal |
2.645700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.702200E-01 |
| Normal-vs-N1 |
5.380000E-01 |
| N0-vs-N1 |
4.073400E-01 |
|
|
